Daiwa Securities Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $88K | Buy |
1,800
+1,518
| +538% | +$74.2K | ﹤0.01% | 1005 |
|
2025
Q1 | $10K | Hold |
282
| – | – | ﹤0.01% | 1095 |
|
2024
Q4 | $11K | Sell |
282
-45
| -14% | -$1.76K | ﹤0.01% | 1111 |
|
2024
Q3 | $15K | Buy |
327
+30
| +10% | +$1.38K | ﹤0.01% | 1113 |
|
2024
Q2 | $16K | Sell |
297
-1,080
| -78% | -$58.2K | ﹤0.01% | 1133 |
|
2024
Q1 | $94K | Sell |
1,377
-88
| -6% | -$6.01K | ﹤0.01% | 1046 |
|
2023
Q4 | $92K | Sell |
1,465
-198
| -12% | -$12.4K | ﹤0.01% | 1022 |
|
2023
Q3 | $75K | Hold |
1,663
| – | – | ﹤0.01% | 1031 |
|
2023
Q2 | $93K | Buy |
1,663
+1,348
| +428% | +$75.4K | ﹤0.01% | 1015 |
|
2023
Q1 | $14K | Hold |
315
| – | – | ﹤0.01% | 1079 |
|
2022
Q4 | $13K | Buy |
315
+26
| +9% | +$1.07K | ﹤0.01% | 1094 |
|
2022
Q3 | $19K | Hold |
289
| – | – | ﹤0.01% | 1093 |
|
2022
Q2 | $18K | Sell |
289
-1,624
| -85% | -$101K | ﹤0.01% | 1111 |
|
2022
Q1 | $120K | Buy |
1,913
+530
| +38% | +$33.2K | ﹤0.01% | 1018 |
|
2021
Q4 | $105K | Buy |
1,383
+548
| +66% | +$41.6K | ﹤0.01% | 1000 |
|
2021
Q3 | $93K | Buy |
835
+686
| +460% | +$76.4K | ﹤0.01% | 995 |
|
2021
Q2 | $24K | Hold |
149
| – | – | ﹤0.01% | 1008 |
|
2021
Q1 | $18K | Buy |
149
+16
| +12% | +$1.93K | ﹤0.01% | 1015 |
|
2020
Q4 | $20K | Sell |
133
-255
| -66% | -$38.3K | ﹤0.01% | 982 |
|
2020
Q3 | $32K | Buy |
388
+52
| +15% | +$4.29K | ﹤0.01% | 955 |
|
2020
Q2 | $32K | Hold |
336
| – | – | ﹤0.01% | 937 |
|
2020
Q1 | $14K | Hold |
336
| – | – | ﹤0.01% | 1022 |
|
2019
Q4 | $19K | Sell |
336
-12
| -3% | -$679 | ﹤0.01% | 1007 |
|
2019
Q3 | $14K | Buy |
348
+16
| +5% | +$644 | ﹤0.01% | 1001 |
|
2019
Q2 | $16K | Hold |
332
| – | – | ﹤0.01% | 1012 |
|
2019
Q1 | $12K | Buy |
332
+78
| +31% | +$2.82K | ﹤0.01% | 1012 |
|
2018
Q4 | $7K | Hold |
254
| – | – | ﹤0.01% | 1013 |
|
2018
Q3 | $11K | Hold |
254
| – | – | ﹤0.01% | 1017 |
|
2018
Q2 | $15K | Hold |
254
| – | – | ﹤0.01% | 1012 |
|
2018
Q1 | $12K | Buy |
+254
| New | +$12K | ﹤0.01% | 1007 |
|